Suppr超能文献

保乳术后放射治疗对 N1mic 期乳腺癌患者生存的影响。

The effect of post mastectomy radiation therapy on survival in breast cancer patients with N1mic disease.

机构信息

Department of Radiation Oncology, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA.

Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, 60612, USA.

出版信息

Breast. 2020 Jun;51:50-56. doi: 10.1016/j.breast.2020.02.009. Epub 2020 Mar 6.

Abstract

BACKGROUND

The role of post mastectomy radiation therapy (PMRT) in patients with N1mic breast cancer has not been well defined. A retrospective analysis was performed using the SEER database to evaluate the impact of PMRT on survival in patients with N1mic breast cancer.

MATERIALS AND METHODS

Women with T1-T2, N1mic, M0 breast cancer who had undergone mastectomy were analyzed. Descriptive statistics were calculated for all variables. Univariate analysis to assess for differences in survival with respect to covariates was performed using the log rank test while multivariate analysis was performed with Cox proportional hazards regression. Sub-cohort analysis with propensity score matching was used to assess differences in survival among patients undergoing PMRT vs no PMRT. Comparisons were considered statistically significant at P < 0.05.

RESULTS

Among 5878 patients, 1202 (20%) underwent PMRT. On univariate analysis, PMRT was a significant predictor of CSS, but not OS. There was no difference in either OS or CSS between the PMRT vs no PMRT groups on multivariate Cox regression analysis and after propensity score matching.

CONCLUSIONS

Among patients with T1-T2, N1mic, M0 breast IDC from the SEER database, there was no difference in either OS or CSS among patients who underwent PMRT vs no PMRT. These results suggest that PMRT does not impact survival among breast cancer patients with N1mic disease. However, additional prospective studies with longer follow up are necessary for further evaluation.

摘要

背景

N1mic 乳腺癌患者术后放疗(PMRT)的作用尚未明确。本研究使用 SEER 数据库进行回顾性分析,旨在评估 PMRT 对 N1mic 乳腺癌患者生存的影响。

材料与方法

纳入 T1-T2、N1mic、M0 期行乳房切除术的女性患者。对所有变量进行描述性统计分析。使用对数秩检验进行单因素分析,以评估与协变量有关的生存差异,同时使用 Cox 比例风险回归进行多因素分析。采用倾向评分匹配进行亚组分析,以评估 PMRT 与非 PMRT 患者的生存差异。P<0.05 为差异有统计学意义。

结果

5878 例患者中,有 1202 例(20%)接受了 PMRT。单因素分析显示,PMRT 是 CSS 的显著预测因子,但不是 OS。多因素 Cox 回归分析和倾向评分匹配后,PMRT 组与非 PMRT 组在 OS 或 CSS 方面均无差异。

结论

SEER 数据库中 T1-T2、N1mic、M0 期 IDC 乳腺癌患者中,PMRT 组与非 PMRT 组在 OS 或 CSS 方面均无差异。这些结果表明,PMRT 不会影响 N1mic 疾病乳腺癌患者的生存。但是,需要进一步的评估,还需要进行具有更长随访时间的前瞻性研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验